TSX: HSM     OTC: HSDT

Call us: +1 877-564-0008

people2

Member, Board of Directors. Chairman, Audit Committee

Tom is currently Chief Financial Officer for Avedro, Inc., a privately held pharmaceutical and medical device company advancing the science and technology of corneal cross-linking and refractive correction.  Tom is a veteran finance executive who has spent his entire career in financial operations at medical technology and biotechnology companies. Most recently, Tom served as Chief Financial Officer of Entellus Medical, Inc., a medical technology company that designs products for the treatment of chronic and recurrent sinusitis, for 10 years including during the company’s initial public offering before transitioning to vice president of finance in May 2016. Prior to this, he served in a variety of executive level financial positions at several organizations, including Digital Gene Technologies, Inc., Centerpulse Spine-Tech, Inc. (now Zimmer Spine, Inc.), and CIMA Labs Inc. (now owned by Teva Pharmaceutical Industries Ltd.). Tom holds a BA in Accounting from the University of Minnesota, Duluth, an MBA in Management from the University of St. Thomas, and is a Certified Public Accountant (inactive).